| scholarly article | Q13442814 |
| P356 | DOI | 10.1099/VIR.0.18974-0 |
| P698 | PubMed publication ID | 12692287 |
| P50 | author | Javier Martín | Q72954508 |
| Francis Delpeyroux | Q60727836 | ||
| P2093 | author name string | Paolo Balestri | |
| Lucia Fiore | |||
| Alessandro Plebani | |||
| Rossella Vivarelli | |||
| Stefano Fiore | |||
| Valentina Donati | |||
| Gabriele Buttinelli | |||
| Anna Rosa Soresina | |||
| Jill Marturano | |||
| P433 | issue | Pt 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | poliomyelitis | Q12195 |
| patient | Q181600 | ||
| Poliovirus | Q70923324 | ||
| P304 | page(s) | 1215-1221 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Journal of General Virology | Q6295245 |
| P1476 | title | Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis | |
| P478 | volume | 84 |
| Q37002529 | A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus |
| Q28478276 | Antiviral activity of 3(2H)- and 6-chloro-3(2H)-isoflavenes against highly diverged, neurovirulent vaccine-derived, type2 poliovirus sewage isolates |
| Q92126384 | Antiviral peptides as promising therapeutic drugs |
| Q47120085 | Are Circulating Type 2 Vaccine-derived Polioviruses (VDPVs) Genetically Distinguishable from Immunodeficiency-associated VDPVs? |
| Q46851078 | Bcgitis and vaccine-derived poliovirus infection in a patient with a novel deletion in RAG1 binding site |
| Q37423069 | Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia. |
| Q41768177 | Evolution of the Sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: need for improvement of current poliovirus surveillance. |
| Q36362236 | High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies |
| Q38323836 | Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication |
| Q34045658 | Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient |
| Q39954932 | Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia |
| Q50624426 | Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child. |
| Q36899024 | Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine |
| Q37683100 | Long-term excretion of vaccine-derived poliovirus by a healthy child |
| Q34143845 | Mechanisms of genetic variation in polioviruses |
| Q33267329 | Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations |
| Q52686332 | New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data. |
| Q36049019 | Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis |
| Q38087428 | Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs). |
| Q38073076 | Polio eradication in India: progress, but environmental surveillance and vigilance still needed |
| Q76368323 | Poliovirus mutants excreted by a chronically infected hypogammaglobulinemic patient establish persistent infections in human intestinal cells |
| Q40242265 | Poliovirus vaccine strains in sewage and river water in South Africa |
| Q36944919 | Potential use of antiviral agents in polio eradication |
| Q81923823 | Prevalence of vaccine-derived polioviruses in sewage and river water in South Africa |
| Q40269934 | Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa |
| Q41921219 | Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry |
| Q31034162 | Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence |
| Q37060273 | Retrospective Analysis of a Local Cessation of Vaccination against Poliomyelitis: a Possible Scenario for the Future |
| Q40004013 | Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece. |
| Q38028997 | Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis |
| Q37743865 | Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine |
| Q53689004 | The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda. |
Search more.